These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 29263823)
1. Relation between Chen Y; Salem M; Boyd M; Bornholdt J; Li Y; Coskun M; Seidelin JB; Sandelin A; Nielsen OH NPJ Genom Med; 2017; 2():3. PubMed ID: 29263823 [TBL] [Abstract][Full Text] [Related]
2. Detection of muramyl dipeptide-sensing pathway defects in patients with Crohn's disease. van Heel DA; Hunt KA; King K; Ghosh S; Gabe SM; Mathew CG; Forbes A; Playford RJ Inflamm Bowel Dis; 2006 Jul; 12(7):598-605. PubMed ID: 16804397 [TBL] [Abstract][Full Text] [Related]
5. Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease. van Heel DA; Ghosh S; Hunt KA; Mathew CG; Forbes A; Jewell DP; Playford RJ Gut; 2005 Nov; 54(11):1553-7. PubMed ID: 15928043 [TBL] [Abstract][Full Text] [Related]
6. Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease. van Heel DA; Ghosh S; Butler M; Hunt KA; Lundberg AM; Ahmad T; McGovern DP; Onnie C; Negoro K; Goldthorpe S; Foxwell BM; Mathew CG; Forbes A; Jewell DP; Playford RJ Lancet; 2005 May 21-27; 365(9473):1794-6. PubMed ID: 15910952 [TBL] [Abstract][Full Text] [Related]
7. Muramyl dipeptide-induced differential gene expression in NOD2 mutant and wild-type Crohn's disease patient-derived dendritic cells. Zelinkova Z; van Beelen AJ; de Kort F; Moerland PD; Ver Loren van Themaat E; te Velde AA; van Deventer SJ; de Jong EC; Hommes DW Inflamm Bowel Dis; 2008 Feb; 14(2):186-94. PubMed ID: 17941075 [TBL] [Abstract][Full Text] [Related]
8. NOD2 engagement induces proinflammatory cytokine production, but not apoptosis, in leukocytes isolated from patients with Crohn's disease. Bodar E; Netea MG; de Jong DJ; Kullberg BJ; Joosten LA; Van der Meer JW Eur Cytokine Netw; 2008 Dec; 19(4):185-9. PubMed ID: 19103524 [TBL] [Abstract][Full Text] [Related]
9. Identifying the Neurogenetic Framework of Crohn's Disease Through Investigative Analysis of the Nucleotide-binding Oligomerization Domain-containing Protein 2 Gene Mutation. Sakibuzzaman M; Moosa SA; Akhter M; Trisha IH; Talib KA Cureus; 2019 Sep; 11(9):e5680. PubMed ID: 31723489 [TBL] [Abstract][Full Text] [Related]
10. Dysfunctional Crohn's Disease-Associated NOD2 Polymorphisms Cannot be Reliably Predicted on the Basis of RIPK2 Binding or Membrane Association. Parkhouse R; Monie TP Front Immunol; 2015; 6():521. PubMed ID: 26500656 [TBL] [Abstract][Full Text] [Related]
11. Molecular Recognition of Muramyl Dipeptide Occurs in the Leucine-rich Repeat Domain of Nod2. Lauro ML; D'Ambrosio EA; Bahnson BJ; Grimes CL ACS Infect Dis; 2017 Apr; 3(4):264-270. PubMed ID: 27748583 [TBL] [Abstract][Full Text] [Related]
14. Enhancement of Muramyl Dipeptide-Dependent NOD2 Activity by a Self-Derived Peptide. Mann JK; Shen J; Park S J Cell Biochem; 2017 May; 118(5):1227-1238. PubMed ID: 27791288 [TBL] [Abstract][Full Text] [Related]
15. Immuno-inhibitory PD-L1 can be induced by a peptidoglycan/NOD2 mediated pathway in primary monocytic cells and is deficient in Crohn's patients with homozygous NOD2 mutations. Hewitt RE; Pele LC; Tremelling M; Metz A; Parkes M; Powell JJ Clin Immunol; 2012 May; 143(2):162-9. PubMed ID: 22397822 [TBL] [Abstract][Full Text] [Related]
16. Towards an understanding of the role of NOD2/CARD15 in the pathogenesis of Crohn's disease. Philpott DJ; Viala J Best Pract Res Clin Gastroenterol; 2004 Jun; 18(3):555-68. PubMed ID: 15157827 [TBL] [Abstract][Full Text] [Related]
17. NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease. Peyrin-Biroulet L; Chamaillard M J Endotoxin Res; 2007; 13(3):135-9. PubMed ID: 17621555 [TBL] [Abstract][Full Text] [Related]
18. Identification of a synthetic muramyl peptide derivative with enhanced Nod2 stimulatory capacity. Rubino SJ; Magalhaes JG; Philpott D; Bahr GM; Blanot D; Girardin SE Innate Immun; 2013 Oct; 19(5):493-503. PubMed ID: 23339926 [TBL] [Abstract][Full Text] [Related]
19. The effect of NOD2 activation on TLR2-mediated cytokine responses is dependent on activation dose and NOD2 genotype. Borm ME; van Bodegraven AA; Mulder CJ; Kraal G; Bouma G Genes Immun; 2008 Apr; 9(3):274-8. PubMed ID: 18340358 [TBL] [Abstract][Full Text] [Related]
20. Identification and biological consequences of the O-GlcNAc modification of the human innate immune receptor, Nod2. Hou CW; Mohanan V; Zachara NE; Grimes CL Glycobiology; 2016 Jan; 26(1):13-8. PubMed ID: 26369908 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]